Mai Capital Management Mustang Bio, Inc. Transaction History

Mai Capital Management

  • $10.1 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$0.32 - $8.27 $6,400 - $165,400
20,000 New
20,000 $7,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $17.9M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email